Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > INTRAVITREAL BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH OR WITHOUT PRIOR TREATMENT WITH PHOTODYNAMIC THERAPY One-Year Results
Publication

Publications

INTRAVITREAL BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH OR WITHOUT PRIOR TREATMENT WITH PHOTODYNAMIC THERAPY One-Year Results

Title
INTRAVITREAL BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH OR WITHOUT PRIOR TREATMENT WITH PHOTODYNAMIC THERAPY One-Year Results
Type
Article in International Scientific Journal
Year
2010
Authors
Ângela Carneiro
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Manuel Falcão
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Brandao, EM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Falcão-Reis F
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Title: RetinaImported from Authenticus Search for Journal Publications
Vol. 30
Pages: 85-92
ISSN: 0275-004X
Other information
Authenticus ID: P-003-CM7
Abstract (EN): Purpose: The purpose of this study was to elucidate the effect of prior photodynamic therapy (PDT) on the efficacy of intravitreal bevacizumab for the treatment of neovascular age-related macular degeneration. Methods: One hundred and nine eyes of 102 patients with neovascular age-related macular degeneration were evaluated-80 eyes without prior treatment (group 1) and 29 with prior PDT (group 2). Best-corrected visual acuity, ocular coherence tomography, and funduscopy were assessed monthly. Results were evaluated at 1, 3, 6, and 12 months. Results: One hundred and one eyes completed a 12-month evaluation. At 12 months, best-corrected visual acuity increased 5.6 letters with treatment (P = 0.001): +5.7 letters in group 1 and +5.4 in group 2 (P = 0.92). Overall, visual acuity improved >= 15 letters in 22.5% of eyes: 24.0% of naive eyes versus 18.5% with prior PDT (P = 0.56). Best-corrected visual acuity loss >= 15 letters occurred in 6 eyes, 5 with naive lesions. An overall reduction in ocular coherence tomography central retinal thickness was observed at all time points. Mean number of injections per eye per year was 5.6, 6.13 in group 1 versus 4.22 in group 2 (P = 0.01). Two retinal pigment epithelial tears, one subretinal macular hemorrhage, and two strokes occurred in naive lesions. Conclusion: The authors showed similar efficacy for intravitreal bevacizumab independently of prior PDT treatment. Eyes with prior PDT needed a statistically significantly lower number of injections to control their lesions. RETINA 30:85-92,2010
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 8
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Switch from Intravitreal Ranibizumab to Bevacizumab for the Treatment of Neovascular Age-Related Macular Degeneration: Clinical Comparison (2014)
Article in International Scientific Journal
Pinheiro Costa, J; Freitas da Costa, P; Manuel Falcão; Brandao, EM; Falcão-Reis F; Ângela Carneiro
Ranibizumab Treatment for Choroidal Neovascularization from Causes Other than Age-Related Macular Degeneration and Pathological Myopia (2011)
Article in International Scientific Journal
Ângela Carneiro; Silva, RM; Veludo, MJ; Barbosa, A; Ruiz Moreno, JM; Manuel Falcão; Brandao, EM; Falcão-Reis F
Comparative study of 1+PRN ranibizumab versus bevacizumab in the clinical setting (2012)
Article in International Scientific Journal
Ângela Carneiro; Mendonca, LS; Manuel Falcão; Fonseca, SL; Brandao, EM; Falcão-Reis F
Choroidal and macular thickness changes induced by cataract surgery (2014)
Article in International Scientific Journal
Manuel Falcão; Goncalves, NM; Freitas Costa, P; Beato, JB; Rocha-Sousa A; Ângela Carneiro; Brandao, EM; Falcão-Reis F

Of the same journal

Early Longitudinal Spectral Domain Optical Coherence Tomography Findings in Subacute Sclerosing Panencephalitis (2017)
Another Publication in an International Scientific Journal
Beato, J; Manuel Falcão; Costa, H; Figueira, L; Santos Silva, R; Penas, S; Brandao, E; Ângela Carneiro; Falcão-Reis F
Short-term efficacy and safety of intravitreal ranibizumab for myopic choroidal neovascularization (2008)
Article in International Scientific Journal
Silva, RM; Ruiz Moreno, JM; Nascimento, J; Ângela Carneiro; Rosa, P; Barbosa, A; Carvalheira, F; Abreu, JRF; Cunha Vaz, JG
RECURRENCE OF VITREOUS AMYLOIDOSIS AND NEED OF SURGICAL REINTERVENTION IN PORTUGUESE PATIENTS WITH FAMILIAL AMYLOIDOSIS ATTR V30M (2011)
Article in International Scientific Journal
beirao, nm; matos, e; beirao, i; costa, pp; torres, p
POSSIBLE ROLE FOR FUNDUS AUTOFLUORESCENCE AS A PREDICTIVE FACTOR FOR VISUAL ACUITY RECOVERY AFTER EPIRETINAL MEMBRANE SURGERY (2014)
Article in International Scientific Journal
Brito, PN; Gomes, NL; Vieira, MP; Faria, PA; Fernandes, AV; Rocha-Sousa A; Falcão-Reis F
INTRAVITREAL RANIBIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION 12-Month Results (2010)
Article in International Scientific Journal
Silva, RM; Ruiz Moreno, JM; Rosa, P; Ângela Carneiro; Nascimento, J; Rito, LF; Cachulo, ML; Carvalheira, F; Murta, JN

See all (10)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-10 at 23:39:30 | Privacy Policy | Personal Data Protection Policy | Whistleblowing